Events

Events 02.13.2008 - BIO CEO & Investor Conference 2008: On February 13th Semafore's CEO Ed Jacobs will present at 2:45 pm (ET) at the Waldorf-Astoria in the Park Avenue Suite

Events 04.04.2006 - Identification of Molecular Markers for Selection of Patients Likely to Respond and Pharmacodynamic Markers of Delivery of Biologically Relevant Dose and Early Response to a Novel Phosphatidylinositol 3-kinase PI3K Inhibitory Prodrug, SF1126

Events 04.04.2006 - In Vitro and In Vivo Preclinical Studies on the Novel PI3 Kinase Inhibitor SF1126

Events 12.08.2004 - Targeting the PI3K pathway in cancer

Events 11.17.2004 - Toward Prostate Cancer Treatment Using SF1126, A Novel Targeted PI3-Kinase Inhibitor

Events 11.08.2004 - Small Molecule PTEN Inhibitors: Therapeutic Applications and Implications Short Proposal

Events 08.27.2004 - In Vivo Efficacy in Brain Cancer Xenograft Models Using a Novel Vascular Targeted PI3-Kinase Inhibitor

Events 07.21.2004 - In Vivo Efficacy in a Prostate Cancer Xenograft Model Using a Novel Targeted PI3-Kinase Inhibitor

Events 06.09.2004 - Novel Targeted PI3-Kinase Inhibitors; First In Vivo Efficacy in Xenograph Cancer Models